Tag Archives: HIV drugs in COVID trials after failure to reduce death

GENEVA: The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality. The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single …

Read More »